Oz Biosciences OVA Antigen mRNA Modified N1-Methyl-Pseudouridine

Oz Biosciences OVA Antigen mRNA Modified N1-Methyl-Pseudouridine

OVA mRNAs have been designed to produce high expression level of Ovalbumin protein. OVA mRNA encodes for OVA protein, a commonly used antigen for immunisation and biochemical studies and also an established model allergen for airway hyper-responsiveness. OZ Biosciences mRNAs are produced by in vitro transcription. mRNAs are stabilised at the 5' end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3' end. Sequences have been optimised to yield improved stability and performance.

Ready-to-use stabilised OVA mRNA

Concentration: 1.0mg/mL in 1mM sodium citrate, pH 6.4.

mRNA length: 1375nt. MW MRNA42 = 445528g/mol; MRNA41 = 451168g/mol; MRNA40 = 448348g/mol

MRNA42 does not bear any additional nucleotide modifications

MRNA41 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses

MRNA40 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Manufacturer Price Quantity
3075049 Oz Biosciences OVA Antigen mRNA Modified N1-Methyl-Pseudouridine OZ BIOSCIENCES
£547.50 (exc VAT) per 100UG
-
+
3075050 Oz Biosciences OVA Antigen mRNA Modified N1-Methyl-Pseudouridine OZ BIOSCIENCES
£250.71 (exc VAT) per 20UG
-
+